RESEARCH ARTICLE
Polysorbate 80 Coated Solid Lipid Nanoparticles for the Delivery of Temozolomide Into the Brain
Pawan Yadav1, Goutam Rath1, Gazal Sharma1, Ranjit Singh2, Amit Kumar Goyal1, *
Article Information
Identifiers and Pagination:
Year: 2018Volume: 8
First Page: 21
Last Page: 28
Publisher Id: TOPHARMJ-8-21
DOI: 10.2174/1874143601808010021
Article History:
Received Date: 22/02/2018Revision Received Date: 03/10/2018
Acceptance Date: 14/10/2018
Electronic publication date: 30/10/2018
Collection year: 2018
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Introduction:
Anti-angiogenic therapy can produce transient regression in tumor in case of Glioblastoma (GBM); however, no prolongation of patient survival rate had so far been achieved.
Methodology:
To address this problem, an effort was made to design and characterize a temozolomide loaded nanosystem for targeting the tumor vasculature in the brain using polymeric nanoparticles. It included the formation of Temozolomide (TMZ) loaded Solid-Lipid Nanoparticles (SLNs) and their conjugation with polysorbate-80 (P-80) which enhanced the penetration of drug to blood-brain barrier resulting in the enhancement of pro-apoptotic activity.
Results:
Conjugating nanoparticles with a tumor-penetrating polymer (P-80) further enhanced the therapeutic efficacy of the drug.
Conclusion:
The animal studies indicated the enhanced potential of the developed system in the effective treatment of glioblastoma.
